Immunohistochemical comparison in ovarian cancer between primary tumors and the corresponding omental and peritoneal lesions demonstrated profound differences in the expression pattern of CD45, CD3, CD8, PD-1 and PD-L1. This evidence concerns the gene PTPRC and ovarian cancer.